


To secure capital growth from a portfolio of securities of companies engaged in Health and Pharmaceuticals and Biotechnology.
| Latest Price | 89.49p | IMA Sector | Specialist |
|---|---|---|---|
| Currency | British Pound | Launch Date | 21/11/2000 |
| Fund Size | £32.28m | Fund Manager | Ali Toutounchi |
| ISIN | GB0001955318 | Dividend | 0.78p |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 89.49p |
| Currency | GBP |
| Change | 0.97p |
| % | 1.10% |
| YTD change | -6.90p |
| YTD % | -7.16% |
| Fund Inception | 21/11/2000 |
|---|---|
| Fund Manager | Ali Toutounchi |
| TER | 1.15 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | -0.09 |
You are here: research